These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7577478)

  • 1. A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer.
    Iaffaioli RV; Tortoriello A; Facchini G; Santangelo M; De Sena G; Gesue G; Bucci L; Scaramellino G; Anastasio E; Finizio A
    Br J Cancer; 1995 Nov; 72(5):1256-8. PubMed ID: 7577478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of vinorelbine and thiotepa in metastatic breast cancer.
    Fabi A; Tonachella R; Savarese A; Cirulli S; Tomao S; Conte E; Cognetti F
    Ann Oncol; 1995 Feb; 6(2):187-9. PubMed ID: 7786825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
    Kornek GV; Haider K; Kwasny W; Hejna M; Raderer M; Meghdadi S; Burger D; Schneeweiss B; Depisch D; Scheithauer W
    Br J Cancer; 1996 Nov; 74(10):1668-73. PubMed ID: 8932353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.
    Kornek GV; Haider K; Kwasny W; Lang F; Krauss G; Hejna M; Raderer M; Weinländer G; Depisch D; Scheithauer W
    Br J Cancer; 1998 Sep; 78(5):673-8. PubMed ID: 9744509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.
    Kornek GV; Ulrich-Pur H; Penz M; Haider K; Kwasny W; Depisch D; Kovats E; Lang F; Schneeweiss B; Scheithauer W
    J Clin Oncol; 2001 Feb; 19(3):621-7. PubMed ID: 11157011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
    Kosmas C; Agelaki S; Giannakakis T; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
    Oncology; 2002; 62(2):103-9. PubMed ID: 11914594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
    Kakolyris S; Kourousis C; Koukourakis M; Androulakis N; Vamvakas L; Agelaki S; Hatzidaki D; Samonis G; Tsiftsis D; Georgoulias V
    Am J Clin Oncol; 1999 Dec; 22(6):568-72. PubMed ID: 10597740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study.
    Polyzos A; Tsavaris N; Kosmas C; Gogas H; Toufexi H; Kosmidis C; Markopoulos C; Giannopoulos A; Papadopoulos O; Stamatiadis D; Kouraklis G
    J Chemother; 2003 Dec; 15(6):607-12. PubMed ID: 14998089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines.
    Berruti A; Sperone P; Bottini A; Gorzegno G; Lorusso V; Brunelli A; Botta M; Tampellini M; Donadio M; Mancarella S; De Lena M; Alquati P; Dogliotti L
    J Clin Oncol; 2000 Oct; 18(19):3370-7. PubMed ID: 11013277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
    Onyenadum A; Gogas H; Markopoulos C; Bafaloukos D; Aravantinos G; Mantzourani M; Koutras A; Tzorakoelefterakis E; Xiros N; Makatsoris T; Fountzilas G; Kalofonos HP
    J Chemother; 2007 Oct; 19(5):582-9. PubMed ID: 18073159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.
    Ibrahim NK; Buzdar AU; Valero V; Dhingra K; Willey J; Hortobagyi GN
    Cancer; 2001 Feb; 91(4):664-71. PubMed ID: 11241232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-escalating study of carboplatin combined with vinorelbine in non-small-cell lung cancer.
    Colleoni M; Boni L; Vicario G; Pancheri F; Sgarbossa G; Nelli P; Calabrò F; Toniolo L; Bortolotti L; Manente P
    Oncology; 1996; 53(5):364-8. PubMed ID: 8784469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
    Antman K; Ayash L; Elias A; Wheeler C; Schwartz G; Mazanet R; Tepler I; Schnipper LE; Frei E
    J Natl Cancer Inst Monogr; 1994; (16):91-4. PubMed ID: 7528031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
    Farhat F; Kattan JG; Ghosn M
    Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
    Livingston RB; Ellis GK; Gralow JR; Williams MA; White R; McGuirt C; Adamkiewicz BB; Long CA
    J Clin Oncol; 1997 Apr; 15(4):1395-400. PubMed ID: 9193331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas.
    Alici S; Coskun U; Alkis N; Sevinc A; Dane F; Gumus M; Ozkan M; Kaya AO; Celenkoglu G; Buyukberber S; Altunbas M; Benekli M;
    Asian Pac J Cancer Prev; 2009; 10(6):1051-5. PubMed ID: 20192582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.